Forbes contributors publish independent expert analyses and insights. I write about tax policy and how it affects business. A cornerstone of U.S. tax policy (and for many other countries) has been to ...

Forbes contributors publish independent expert analyses and insights. Nathan Goldman is a tax prof. at NC State Univ. Companies with significant R&D expenses celebrated on July 4, 2025, when President ...

In this article, we will be taking a look at the 20 largest R&D companies in the world. If you want to go straight to the top five companies, you can go directly to see the 5 Largest R&D Companies in ...

In August 2026, Lam Research announced plans to invest more than US$3.00 billion over five years to expand its global R&D lab ...

Ben McClure is a seasoned venture finance advisor with 10+ years of experience helping CEOs secure early-stage investments. Get personalized, AI-powered answers built on 27+ years of trusted expertise ...

The R&D Tax Credit changes made in summer 2025 allow taxpayers meeting certain criteria to make a retroactive election to deduct, versus amortize research and experimentation (R&E) expenses. The One ...

The global stage of innovation is once again shifting, and where Silicon Valley once dominated over all, other equally ...

Forget the glorious successes of past breakthroughs—the real justification for research investment is what we get for our money. Here’s what economists say. MIT Technology Review Explains: Let our ...

The parliamentary standing committee flagged uneven R&D spending, weak patent commercialisation and gaps in long-term talent planning in its report tabled in Parliament.

The pharmaceutical industry is grappling with diminishing R&D productivity. Our estimates suggest that the internal rate of return (IRR) on small-molecule R&D is now ∼7.5% (Fig. 1; see Supplementary ...